Galeterone (1) and its C-3 analogs are of substantial
interest because of their multitarget anticancer activities, including
AR and Mnk degrading activities. Here, we describe improved and efficient
procedures for the gram-scale synthesis of 3β-(1H-imidazole-1-yl)-17-(1H-benzimidazole-1-yl)-androsta-5,16-diene
(galeterone 3β-imidazole, 2) and 3β-(pyridine-4-ylmethoxy)-17-(1H-benzimidazol-1-yl)androsta-5,16-diene (galeterone 3β-pyridine
methoxylate, 3). Whereas compound 2 was
synthesized in 63% overall yield from galeterone (1)
over four steps, via key intermediate, 3β-azido galeterone (8); compound 3 was synthesized in 61% overall
yield from 1 in one step. This article also reports on
the facile synthesis of other potential AR/Mnk degrading agents (ARDAs/MNKDAs),
including galeterone 3α-imidazole (5) and galeterone
3β-amine (10), both in excellent overall yields.
Notably, except for the one-step synthesis of compound 3 which required purification by flash column chromatography, none
of the intermediates and target compound 2 required extensive
chromatographic purifications or multiple crystallizations.